WO2024184727 - ALPHA-AMYLASE VARIANTS
National phase entry is expected:
Publication Number
WO/2024/184727
Publication Date
12.09.2024
International Application No.
PCT/IB2024/051877
International Filing Date
27.02.2024
Title **
[English]
ALPHA-AMYLASE VARIANTS
[French]
VARIANTS D'ALPHA-AMYLASE
Applicants **
DANSTAR FERMENT AG
Inventors
ARGYROS, Aaron
PANAITIU, Alexandra-Elena
WOODBREY, Anne K.
Priority Data
PCT/IB2023/052263
09.03.2023
IB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2794 | |
| EPO | Filing, Examination, Granting | 11517 | |
| Japan | Filing, Examination, Granting | 2185 | |
| South Korea | Filing, Examination, Granting | 2130 | |
| USA | Filing, Examination, Granting | 5790 |
Total:
24,416
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure concerns variant polypeptides having alpha-amylase activity exhibiting higher enzymatic activity, lower dependence on the presence of a metallic ion, higher thermostability and/or higher resistance to chelation.[French]
La présente invention concerne des polypeptides variants ayant une activité alpha-amylase présentant une activité enzymatique supérieure, une dépendance inférieure à la présence d'un ion métallique, une thermostabilité supérieure et/ou une résistance à la chélation plus élevée.